Gluten Free Food Market to reach at valuation of US$4.9 bn

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Gluten Free Food Market to reach at valuation of US$4.9 bn by 2021 - New Investment Opportunities, Trends & Forecast 2015 - 2021

Albany, NY, May 25, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research has published a new market study, titled “Gluten Free Food Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2021.” The report says that the global gluten-free food market will reach a valuation of US$4.9 bn by 2021, increasing from US$2.8 bn in 2014. This will amount to a CAGR of 7.7% between 2015 and 2021. Displaying a volume growth at a CAGR of 6.1% from 2015 to 2021, this market will rise to 423.0 (‘000) metric tons by 2021, increasing from 277.2 (‘000) metric tons in 2014. 

The increasing number of individuals that have gluten sensitivity and/or celiac disease is the major factor driving the gluten-free food market. Food free of gluten also aid in weight management and overall health management programs, further driving its demand. Other than individuals with celiac disease, a gluten-free diet is also popular due to the increasing awareness among consumers for signs of gluten sensitivity on consuming foods that contain gluten. This will also bolster the growth of this market during the forecast period. 

Get free research PDF for more Professional and Technical insights: http://www.transparencymarketresearch.com/sam...ep_id=1509   

Gluten is present in grains such as barley, wheat, rye, and a hybrid between wheat and rye called triticale. Gluten present in foods causes inflammation of the small intestine of individuals with celiac disease. For these individuals, a gluten-free diet helps control celiac disease considerably. 

The report on the global gluten-free food market presents market data on the basis of product type and geography. On the basis of product type, baby food, bakery products, ready-to-eat meals, and pasta are the segments of the market. Of all, gluten-free bakery products lead the overall market. In the bakery product segment, innovative processes and the use of gluten substitutes that give the same flavor as gluten without the digestive problems are favoring the growth of the gluten-free food market. 

Research Press Release: http://www.transparencymarketresearch.com/pre...market.htm  

Regionally, Europe is the largest market for gluten-free food in terms of both revenue and volume. In 2014, the region held a share of 52.5% in the global market by revenue. In this region, individuals are perceiving the discomfort associated with a gluten-rich diet and the increasing awareness about gluten intolerance is a major reason for the strong share of the Europe gluten-free food market in the global market.  

In France, the public perception of gluten intolerance as being linked with obesity is propelling the demand for gluten-free foods. Consumers think that gluten-free food can help reduce weight, which is propelling the market in much of Western Europe. A considerably large chunk of the health-conscious young population supporting a gluten-free diet is favoring the growth of the France gluten-free food market. Europe was followed by North America, with a share of 23.2%.in the global market in 2014. 

The global gluten free food market has been segmented as follows: 

Global Gluten Free Food Market by Product Type

  • Gluten free bakery products
  • Gluten free baby food
  • Gluten free pasta
  • Gluten free ready meals 

Global Gluten Free Food Market by Geography

North America

  • U.S
  • Canada

Europe

  • Germany
  • Italy
  • France
  • Rest of Europe

Asia Pacific

  • Australia
  • Rest of Asia Pacific

Middle East and Africa

Latin America  

Other Research Reports:

About TMR  

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decisionmakers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Blog: http://www.europlat.org/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading